HotAir hotair.com 21 Jul, 2021 23:45 am

The dark side of the $26B opioid settlement – HotAir

The dark side of the $26B opioid settlement – HotAir
Follow the money

While nothing has been finalized yet, the New York Times is reporting that a deal may be near that would end thousands of lawsuits against three of the nation’s largest pharmaceutical distributors and pharmaceutical giant Johnson & Johnson.The three largest pharmaceutical distributors and Johnson & Johnson are on the verge of a $26 billion deal with states and municipalities that would settle thousands of lawsuits over their role in the opioid epidemic and pay for addiction and prevention services nationwide.The settlement would not conclude all of the multifaceted nationwide opioid litigation but would end legal action against some of the companies with the deepest pockets in the pharmaceutical supply chain: the country’s major medical distributors, Cardinal Health, McKesson and AmerisourceBergen, along with the pharmaceutical giant Johnson & Johnson.But I’ve yet to see a single example of Johnson & Johnson producing and selling a drug that hasn’t been approved by the FDA.

Much of the money would go toward funding addiction recovery and prevention services.As for the distributors (Cardinal Health, McKesson and AmerisourceBergen), their role in all of this is to obtain the drugs from J&J as needed and fill orders from doctors, pharmacies, and whoever else is authorized to place such orders.

Read full story at hotair.com